Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology. 2011 Feb; 140(2):497-507.e2.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Carcinoma, Hepatocellular
Carcinoma, Hepatocellular
Chemoembolization, Therapeutic
Chemoembolization, Therapeutic
Clinical Trials, Phase II as Topic
Clinical Trials, Phase II as Topic
Disease Progression
Disease Progression
Embolization, Therapeutic
Embolization, Therapeutic
Female
Female
Humans
Humans
Liver Neoplasms
Liver Neoplasms
Male
Male
Microspheres
Microspheres
Middle Aged
Middle Aged
Neoplasm Staging
Neoplasm Staging
Radiopharmaceuticals
Radiopharmaceuticals
Randomized Controlled Trials as Topic
Randomized Controlled Trials as Topic
Standard of Care
Standard of Care
Treatment Outcome
Treatment Outcome
Yttrium Radioisotopes
Yttrium Radioisotopes